CIRBP and cancer: In hepatocellular carcinoma (HCC), CIRP has been proposed to promote carcinogenesis by controlling ROS accumulation and cancer stem/progenitor cell expansion, and risk of HCC recurrence is positively correlated with Cirp expression in liver [137].